InnoCAT ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Wearable Electromechanical Insulin Delivery Device

Health Tech & Life Sciences
Active
Seed Givat Ela, Israel Founded 2021
LinkedIn
Last updated 2026-06-18
Total raised
Last: Grant 2024-01
Stage
Seed
Founded
2021
Headcount
5
HQ
Givat Ela, Israel
Sector
Health Tech & Life Sciences

About

InnoCAT develops a wearable electromechanical device for insulin delivery, designed to simplify diabetes management while improving patient comfort and safety. The company’s proprietary pump architecture integrates user-centric design with efficient electromechanical components to achieve high wearability, usability, and reliability. InnoCAT emphasizes manufacturability and cost efficiency from the outset, ensuring a low cost of goods and scalable production. Its business model is built around profitability through design simplicity and streamlined assembly processes. By partnering with leading medical device manufacturers, InnoCAT aims to deliver a sustainable and commercially viable insulin pump that balances clinical performance with user convenience

Funding history · 2 rounds · — total

2023-12
Grant Undisclosed
2023-01
Seed Undisclosed

Headcount over time

From 4 (2025-10) to 5 (2026-01) · +1 (+25%) · 2 points · source: Finder history + radar grounding
50 2025-10 2026-01

Q&A

What is InnoCAT's primary focus?
InnoCAT develops a wearable electromechanical device for insulin delivery, aiming to simplify diabetes management and improve patient comfort and safety.
When was InnoCAT founded?
InnoCAT was founded in February 2021.
What is InnoCAT's current funding stage?
InnoCAT is currently in the Seed stage.
Which organization invested in InnoCAT's latest funding round?
In January 2024, InnoCAT received a Grant from the Israel Innovation Authority.
Who is the CEO of InnoCAT?
Yishai Ben David is the CEO and a founder of InnoCAT.
What is InnoCAT's business model?
InnoCAT's business model focuses on profitability through design simplicity and streamlined assembly processes, partnering with leading medical device manufacturers.
What sectors does InnoCAT operate in?
InnoCAT operates in the Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Medical Devices, and Medical Treatment & Therapeutics sectors.

Team · 1

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2CB2B2C

Tags

diabetesdrug-deliverytreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/81941536

Identifiers & details

Founded2021-2
Employees (exact)5

Radar intelligence

Patents

EPO4

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516351566
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-02-25
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events5 — annual_report (2), shares_capital (2), other (1)
Registered addressנווה איתן 16 גבעת אלה

Recent registry events

DateEvent
2025-08-27דו~ח שנתי-הסרת בעל תפקיד
2025-09-10הקצאת מניות
2025-09-09שינוי בתקנון
2025-09-09שינוי בהרכב הון - מניות-פיצול מניה
2026-07-01דו~ח שנתי